Transcrip offers experts to augment in-house drug development

By Gareth Macdonald

- Last updated on GMT

Related tags Drug development Partnership Pharmacology Pharmaceutical industry

Transcrip offers experts to augment in-house drug development
Transcrip Partners’ “augmentation” solution for contract R&D “differs from the normal consultancy alternative by fielding ‘doers’ who can think strategically and ‘thinkers’ who are happy to get their hands dirty” according to senior partner Paul Branthwaite.

The international partnership consists of almost 20 pharma industry experts and academics who work with clients’ in-house drug development teams on a contractual basis.

As Branthwaite explained Transcrip aims to “provide knowledge and operational capability in drug development in its widest context, working across multiple therapeutic and ‘functional’ areas.”

Already substantial by consulting group standards in the pharma space, it offers a flexible resourcing model that allows clients to access Partners’ capabilities to fill skill, experience and/or resource gaps, by integrating with and augmenting client teams​.”

Related news

Related products

show more

Drug Solubility and the Need for Speed

Drug Solubility and the Need for Speed

Lonza Small Molecules | 28-Mar-2023 | Technical / White Paper

A growing number of new chemical entities are highly insoluble, leading to problems with bioavailability. Drug manufacturers therefore have to find ways...

Are You Prepared to Meet the New FDA Guidelines?

Are You Prepared to Meet the New FDA Guidelines?

Elligo Health Research® | 23-Mar-2023 | Insight Guide

On April 15, 2022, the U.S. Food and Drug Administration issued a new draft guidance to clinical research sponsors on creating a plan to enroll more participants...

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 10-Mar-2023 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Elligo Health Research® | 10-Mar-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

Related suppliers

Follow us

Products

View more

Webinars